Signum Biosciences' Grant - VI Round

Signum Biosciences raised a round of funding on January 21, 2010. Investors include Alzheimer's Drug Discovery Foundation.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Grant - VI Round: